253
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of Renal Function Profile in Human Visceral Leishmaniasis (Kala-Azar) Patients: A Case of Western Tigray, Ethiopia

, ORCID Icon & ORCID Icon
Pages 21-33 | Received 14 Mar 2023, Accepted 16 Jun 2023, Published online: 28 Jun 2023

References

  • Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63(12):e202–e64. doi:10.1093/cid/ciw670
  • World Health Organization. Global leishmaniasis surveillance: 2019–2020, a baseline for the 2030 roadmap. Wkly Epidemiol Rec. 2021;96(35):401–420.
  • Silva Junior G, Barros EJG, Daher EDF. Kidney involvement in leishmaniasis—a review. Braz J Infect Dis. 2014;18:434–440. doi:10.1016/j.bjid.2013.11.013
  • Kobets T, Grekov I, Lipoldova M. Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem. 2012;19(10):1443–1474. doi:10.2174/092986712799828300
  • Mondiale de la Santé O; World Health Organization. Global leishmaniasis update, 2006–2015: a turning point in leishmaniasis surveillance–Le point sur la situation mondiale de la leishmaniose, 2006–2015: un tournant dans la surveillance de la maladie. Wkly Epidemiol Rec. 2017;92(38):557–565.
  • World Health Organization. Leishmaniasis. World Health Organization; 2018. Available from: https://www.who.int/leishmaniasis/en/. Accessed June 22, 2023.
  • Hailu A, Gebre-Micheal T, Berhe N, Balkew M. Epidemiology and Ecology of Health and Disease in Ethiopia: Leishmaniasis in Ethiopia. Addis Ababa: Shama Press; 2006:15–634.
  • Leta S, Dao THT, Mesele F, Alemayehu G. Visceral leishmaniasis in Ethiopia: an evolving disease. PLoS Negl Trop Dis. 2014;8(9):e3131. doi:10.1371/journal.pntd.0003131
  • Dantas-Torres F, Brandão-Filho SP. Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control. Rev Inst Med Trop Sao Paulo. 2006;48:151–156. doi:10.1590/S0036-46652006000300007
  • Gelanew T, Kuhls K, Hurissa Z, et al. Inference of population structure of Leishmania donovani strains isolated from different Ethiopian visceral leishmaniasis endemic areas. PLoS Negl Trop Dis. 2010;4(11):e889. doi:10.1371/journal.pntd.0000889
  • Tesfaye EFK, Terefe B, Enawgaw B. Haematological abnormalities in visceral leishmaniasis patients attending Gondar University Hospital; Retrospective Study. Int J HIV AIDS Prev Educ Behav Sci. 2017;3(5):48. doi:10.11648/j.ijhpebs.20170305.11
  • Van Griensven J, Diro E. Visceral leishmaniasis. Infect Dis Clin. 2012;26(2):309–322. doi:10.1016/j.idc.2012.03.005
  • Kumar R, Nylén S. Immunobiology of visceral leishmaniasis. Front Immunol. 2012;3:251. doi:10.3389/fimmu.2012.00251
  • Ogedegbe HO. Renal function tests: a clinical laboratory perspective. Lab Med. 2007;38(5):295–304. doi:10.1309/RWG5DY7RG1CYBUR7
  • Rosner MH, Bolton WK. Renal function testing. Am J Kidney Dis. 2006;47(1):174–183. doi:10.1053/j.ajkd.2005.08.038
  • Norris KC, Smoyer KE, Rolland C, Van Der Vaart J, Grubb EB. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018;19(1). doi:10.1186/s12882-018-0821-9
  • Langfred CW, Rockmann KW. The push and pull of autonomy: the tension between individual autonomy and organizational control in knowledge work. Group Organ Manag. 2016;41(5):629–657. doi:10.1177/1059601116668971
  • Barrett K, Barman S, Boitano S, Brooks H. General principles and energy production in medical physiology. In: Ganong’s Review of Medical Physiology. 25th ed. New York: McGraw-Hill Education; 2016.
  • Scanlon VC, Sanders T. Essentials of Anatomy and Physiology. FA Davis; 2018.
  • Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 1998;32(6):992–999. doi:10.1016/S0272-6386(98)70074-5
  • Eknoyan G, Lameire N, Eckardt KU, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:5–14.
  • Abubakar I, Tillmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171.
  • Lima Verde FA, Lima Verde IA, Silva Junior GB, Daher EF, Lima Verde EM, Lima Verde EM. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol. 2007;20(4):430–436.
  • Alcântara SD, Santana LRL, Evangelista PD, Teixeira AC, Silva Junior GBD, Daher EDF. Renal dysfunction in Leishmaniasis and Chagas disease coinfection: a case report. Rev Inst Med Trop Sao Paulo. 2018;60. doi:10.1590/s1678-9946201860073
  • Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz DN. Renal involvement in leishmaniasis: a review of the literature. Clin Kidney J. 2011;4(3):147–152. doi:10.1093/ndtplus/sfr008
  • Daher EF, Evangelista LF, Silva Júnior GB, et al. Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil. Braz J Infect Dis. 2008;12(4):154.
  • Efstratiadis G, Boura E, Giamalis P, et al. Renal involvement in a patient with visceral leishmaniasis. Nephrol Dial Transplant. 2006;21(1):235–236. doi:10.1093/ndt/gfi157
  • Salgado FN, Ferreira TMA, Costa JM. Involvement of the renal function in patients with visceral leishmaniasis (kala-azar). Rev Soc Bras Med Trop. 2003;36(2):215.
  • Reis AB, Martins-Filho OA, Teixeira-Carvalho A, et al. Systemic and compartmentalized immune response in canine visceral leishmaniasis. Vet Immunol Immunopathol. 2009;128(1–3):87–95. doi:10.1016/j.vetimm.2008.10.307
  • Bates I, Ekem I. Haematological aspects of tropical diseases. Postgrad Haematol. 2007;2007:979–993.
  • Higgins C. Urea and the clinical value of measuring blood urea concentration. Acutecaretesting Org. 2016;22:1–6.
  • De Francesco Daher E, Martins Dos Santos G, Daher EDF, Santos GMD, Neto AS, Verde EML. Renal tubular dysfunction in human visceral leishmaniasis (Kala-azar). Clin Nephrol. 2009;71(5):492–500. doi:10.5414/CNP71492
  • Verde FAL, Verde FA, Veronese FJV, Neto A, Fuc G, Verde EML. Hyponatremia in visceral leishmaniasis. Rev Inst Med Trop Sao Paulo. 2010;52:253–258. doi:10.1590/S0036-46652010000500006
  • Lieberthal W, Nigam SK. Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol Ren Physiol. 1998;275(5):F623–F32. doi:10.1152/ajprenal.1998.275.5.F623
  • Macedo E, Mehta RL. Prerenal failure: from old concepts to new paradigms. Curr Opin Crit Care. 2009;15(6):467. doi:10.1097/MCC.0b013e328332f6e3
  • Manoeuvrier G, Bach-Ngohou K, Batard E, Masson D, Trewick D. Diagnostic performance of serum blood urea nitrogen to creatinine ratio for distinguishing prerenal from intrinsic acute kidney injury in the emergency department. BMC Nephrol. 2017;18(1):1–7. doi:10.1186/s12882-017-0591-9
  • Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant. 2013;28(2):254–273. doi:10.1093/ndt/gfs380
  • Gu L, Huang L, Wu H, Lou Q, Bian R. Serum uric acid to creatinine ratio: a predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function. Diab Vasc Dis Res. 2017;14(3):221–225. doi:10.1177/1479164116680318
  • Brito DE, Neto VA, Duarte IS, Penna DO, Neto VA. Glomerular involvement in human kala-azar. A light, immunofluorescent, and electron microscopic study based on kidney biopsies. Am J Trop Med Hyg. 1975;24(1):9–18. doi:10.4269/ajtmh.1975.24.9
  • Kaplan AA, Kohn OF. Fractional excretion of urea as a guide to renal dysfunction. Am J Nephrol. 1992;12(1–2):49–54. doi:10.1159/000168417
  • Weisinger JR, Pinto A, Velazquez GA, et al. Clinical and histological kidney involvement in human kala-azar. Am J Trop Med Hyg. 1978;27(2 Pt 1):357–359. doi:10.4269/ajtmh.1978.27.357
  • Tiao JY-H, Semmens JB, Masarei JRL, Lawrence-Brown MMD. The effect of age on serum creatinine levels in an aging population: relevance to vascular surgery. Cardiovasc Surg. 2002;10(5):445–451. doi:10.1177/096721090201000501
  • Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419.
  • MachasNúñez JF, Cameron JS, Oreopoulos DG. The Aging Kidney in Health and Disease. Springer; 2008.
  • Oliveira MJ, Júnior GBS, Abreu KLS, et al. Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). Am J Trop Med Hyg. 2010;82(3):449. doi:10.4269/ajtmh.2010.09-0571
  • Musch W, Verfaillie L, Decaux G. Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2006;1(5):909–914. doi:10.2215/CJN.00320106
  • Seki M, Nakayama M, Sakoh T, et al. Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3–5 chronic kidney disease: a prospective observational study. BMC Nephrol. 2019;20(1):1–10. doi:10.1186/s12882-019-1306-1
  • Gerezgiher K. Evaluation of Renal Function Profile in Human Visceral Leishmaniasis (Kala-Azar) Patients. Addis Ababa, Ethiopia: Addis Ababa University; 2020.